Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories abbott India Limited — Revenue from Operations (INR Crores)
Abbott India Limited (NSE: ABBOTINDIA) Quarterly & Annual Filings
Latest, FY2025
6,409
Period ended Dec 31, 2025
Change on a year earlier
+9.6%
5,849 in FY2024
History
11 years
Since FY2015
Sources
1
Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up abbott india limited — revenue from operations (inr crores)
- Abbott India — Operating Profit / EBITDA (INR Crores)1,695 · FY2025
- Abbott India — Operating Profit Margin (%)26.0% · FY2025
- Abbott India — Operating Expenses (INR Crores)4,714 · FY2025
- Abbott India — Other / Treasury Income (INR Crores)275 · FY2025
- Abbott India — Depreciation & Amortization (INR Crores)72 · FY2025
- Abbott India — Profit Before Tax (INR Crores)1,887 · FY2025
- Abbott India — Effective Tax Rate (%)25.0% · FY2025
- Abbott India — Net Profit (INR Crores)1,414 · FY2025
- Abbott India — Earnings Per Share (INR / Share)666 · FY2025
- Abbott India — Dividend Payout Ratio (%)71.0% · FY2025
Cite this data
StockData. (2026). Abbott Laboratories Abbott India Limited — Revenue from Operations (INR Crores), annual FY2015–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ind-sales
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.